VOYA Investment Management’s Monte Rosa Therapeutics GLUE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.4K | Buy |
12,958
+1,345
| +12% | +$6.07K | ﹤0.01% | 2575 |
|
|
2025
Q1 | $53.9K | Sell |
11,613
-552
| -5% | -$2.56K | ﹤0.01% | 2535 |
|
|
2024
Q4 | $84.4K | Sell |
12,165
-957
| -7% | -$6.64K | ﹤0.01% | 2610 |
|
|
2024
Q3 | $69.5K | Buy |
13,122
+1,969
| +18% | +$10.4K | ﹤0.01% | 2728 |
|
|
2024
Q2 | $41.7K | Buy |
11,153
+595
| +6% | +$2.23K | ﹤0.01% | 2803 |
|
|
2024
Q1 | $74.4K | Sell |
10,558
-1,907
| -15% | -$13.4K | ﹤0.01% | 2677 |
|
|
2023
Q4 | $70.4K | Sell |
12,465
-80,365
| -87% | -$454K | ﹤0.01% | 2817 |
|
|
2023
Q3 | $445K | Hold |
92,830
| – | – | ﹤0.01% | 2100 |
|
|
2023
Q2 | $636K | Buy |
92,830
+502
| +0.5% | +$3.44K | ﹤0.01% | 1945 |
|
|
2023
Q1 | $719K | Hold |
92,328
| – | – | ﹤0.01% | 1836 |
|
|
2022
Q4 | $703K | Sell |
92,328
-6,874
| -7% | -$52.3K | ﹤0.01% | 1832 |
|
|
2022
Q3 | $810K | Buy |
99,202
+88,772
| +851% | +$725K | ﹤0.01% | 1742 |
|
|
2022
Q2 | $101K | Buy |
+10,430
| New | +$101K | ﹤0.01% | 2615 |
|
|
2022
Q1 | – | Sell |
-95,355
| Closed | -$1.95M | – | 2694 |
|
|
2021
Q4 | $1.95M | Sell |
95,355
-7,466
| -7% | -$152K | ﹤0.01% | 1165 |
|
|
2021
Q3 | $2.29M | Sell |
102,821
-1,356
| -1% | -$30.2K | ﹤0.01% | 1113 |
|
|
2021
Q2 | $2.36M | Buy |
+104,177
| New | +$2.36M | ﹤0.01% | 1130 |
|